G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization

R Z Azma1, N Hidayati, N R Farisah

  • 1Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia. zahratul@ppukm.ukm.my

Insights

Screening for Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Malaysia can be improved. The OSMMR-D kit assay provides accurate G6PD activity measurements, aiding in the detection of partial deficiencies.

Area of Science:

  • Biochemistry
  • Clinical Diagnostics
  • Genetics

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common cause of neonatal jaundice in Malaysia.
  • Current screening methods like the fluorescent spot test (FST) may not detect partial G6PD deficiency.

Purpose of the Study:

  • To evaluate the OSMMR-D kit assay for quantifying G6PD activity and hemoglobin (Hb) concentration.
  • To establish normal reference ranges for G6PD activity in Malaysian neonates and adults.
  • To determine cut-off points for partial G6PD deficiency.

Main Methods:

  • The OSMMR-D kit assay was used to measure G6PD activity and Hb concentration in EDTA blood samples.
  • Samples were obtained from 94 neonates and 295 adults with normal Hb and FST results.
  • Statistical analysis was performed to establish normal ranges and cut-off points.

Main Results:

  • Normal mean G6PD activity was 12.43 +/- 2.28 U/gHb for neonates and 9.21 +/- 2.6 U/gHb for adults.
  • Reference ranges were established as 10.15-14.71 U/gHb for neonates and 6.61-11.81 U/gHb for adults.
  • Cut-off points for partial deficiency were determined for both neonates and adults, with no significant differences observed between racial groups or genders.

Conclusions:

  • The OSMMR-D kit assay provides a simple, reproducible, and accurate method for quantifying G6PD activity, normalized for Hb concentration.
  • This assay can aid in the detection of partial G6PD deficiency, improving upon existing screening methods.
  • Established reference ranges and cut-off points are valuable for clinical diagnostics in Malaysia.